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Abstract
Background: MicroRNAs (miRNAs) are a class of small RNAs that are implicated in the control of eukaryotic gene expression
by binding to the 39UTR of target mRNAs. Several algorithms have been developed for miRNA target prediction however,
experimental validation is still essential for the correct identification of miRNA targets. We have recently predicted that
Neuropilin2a (Nrp2a), a vascular endothelial growth factor receptor which is essential for normal developmental
angiogenesis in zebrafish, is a dre-miR-2188 target.
Methodology: Here we show that dre-miR-2188 targets the 39-untranslated region (39UTR) of Nrp2a mRNA and is implicated
in proper intersegmental vessel development in vivo. Over expression of miR-2188 in zebrafish embryos down regulates
Nrp2a expression and results in intersegmental vessel disruption, while its silencing increases Nrp2a expression and
intersegmental vessel sprouting. An in vivo GFP sensor assay based on a fusion between the GFP coding region and the
Nrp2a 39UTR confirms that miR-2188 binds to the 39UTR of Nrp2a and inhibits protein translation.
Conclusions: We demonstrate that miR-2188 targets Nrp2a and affects intersegmental vessel development in zebrafish
embryos.
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Introduction
MicroRNAs (miRNAs) regulate gene expression at the transla-
tional level by binding to the 39untranslated region (39UTR) of
target mRNAs and by activating their degradation or inhibiting
their translation [1–4]. Eukaryotic genomes encode hundreds to
thousands of miRNAs [2] and a single miRNA can regulate the
expression of hundreds of genes while one gene can be regulated
by more than one miRNA [1,5,6]. These molecules are implicated
in the regulation of several biological processes, are important for
normal development and physiology [7–11] and their deregulation
is implicated in disease [12–14]. Knowledge of miRNA targets is
therefore pivotal to understand the function of these small non-
coding RNA molecules. Our group has recently identified novel
zebrafish miRNAs and identified putative targets for some of those
miRNAs [15]. Our algorithm predicted Nrp2a, a VEGF co-
receptor involved in developmental angiogenesis, as a miR-2188
target suggesting that this miRNA may be involved in the
regulation of this process.
Neuropilins (Nrps) are expressed in the vascular system with
some degree of vessel type specificity in human, mouse, chicken
and zebrafish embryos [16] and mediate normal developmental
angiogenesis [17–19], which is a process by which new blood
vessels form in response to external stimuli sensed by vascular
endothelial cells. Disruption of this process leads to abnormal
vessel growth and contributes to ischemic, inflammatory and
immune disorders [20]. Although Nrps are not able to initiate
signaling pathways by themselves and require interaction with
other co-receptors, such as the VEGFRs (VEGFR-1, VEGFR-2
and VEGFR-3) [21], their deregulation is implicated in patholog-
ical angiogenesis in tumors and retinal disease [22,23].
In zebrafish there are 4 Neuropilin genes, namely Nrp1a,
Nrp1b, Nrp2a and Nrp2b [19,24]. Nrp2a, the predicted target of
miR-2188, is an ortholog of human Nrp2 that interacts with
VEGFR2 and is required for correct development of major
intersegmental vessels (ISVs) in zebrafish embryos [19,24].
Knocking down Nrp2a in zebrafish embryos results in arterio-
venous malformations in the tail and irregular ISV patterning,
while double knockdowns (Nrp2a and Vegf) increase vasculature
defects and circulation arrest, which is not observed in single
knockdowns [19]. In other words, there is physiological
interdependence between Nrp2a and Vegf during embryonic
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39417development and Nrp2a is likely involved in angiogenesis.
Indeed, over expression of Nrp2, the human ortholog of Nrp2a,
enhances vessel proliferation and migration induced by VEGF,
suggesting that Nrp2 increases the response to VEGF and plays
an important role in vessel proliferation [25]. However, little is
known about the regulation of Nrp2a by miRNAs.
Figure 1. Expression of miR-2188 and Nrp2a in zebrafish embryos. A) ISH of miR-2188 at 24 hpf showed low expression on the trunck and
tail, however it increased at 48 hpf between the somite boundaries. Arrows indicate hybridization signal. B) Nrp2a ISH at 24 and 48 pf. At 24hpf Nrp2a
was predominantly expressed in the head and somitic regions, while at 48 hpf its expression was restricted to the brain and romboencephalon. There
was an indirect correlation between miR-2188 and Nrp2a expression. Increasing miR-2188 levels through development were accompanied by
decreasing Nrp2a expression between the somite boundaries. All embryos are in lateral view, anterior to left. Microscopic pictures were taken with
6,3x magnification.
doi:10.1371/journal.pone.0039417.g001
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angiogenesis. The miRNAs implicated in angiogenesis can be
classified as pro-angiomiRs and anti-angiomiRs. The former
promotes angiogenesis by targeting negative regulators of angio-
genesis and the latter inhibits angiogenesis by targeting positive
regulators of angiogenesis [26]. For instance, miR-92a (miR-
17,92 cluster) is expressed in vascular endothelial cells and
suppresses the function of pro-angiogenic proteins by inhibiting
translation of their mRNAs [27]. In zebrafish embryos, over
expression of this anti-angiomiR causes severe defects in vessel
formation [27]. Conversely, miR-126 is a pro-angiomiR and
promotes VEGF signaling by inhibiting the negative regulators of
the VEGF pathway, i.e., Spred1 and Pik3r2 [28,29]. This miRNA is
required for the maintenance of vascular structure in vivo in mice
and in zebrafish and works as an endothelial cell-specific regulator
of angiogenic signaling. Deletion of miR-126 causes loss of
vascular integrity which is characterized by leaky vessels,
hemorrhage and partial embryonic lethality in mice [29]. In
zebrafish, knockdown of this miRNA also causes hemorrhage and
collapse of the dorsal aorta and primary cardinal veins, indicating
that miR-126 function is conserved in vertebrates [28]. miR-296 is
also a pro-angiomiR that promotes angiogenesis in vitro [30] and
injection of a miR-296 antagomir inhibits glioma angiogenesis in
vivo, supporting a role for this miRNA in promoting angiogenesis
in tumors [26]. These findings indicate therefore that the VEGF
pathway and angiogenesis can be regulated at different levels by
miRNAs, suggesting that elucidation of the biology of angiomiRs
is fundamental to understand angiogenesis.
Here, we show that dre-miR-2188 targets Nrp2a and has an
important role in modulating ISV development in zebrafish
embryos. Over expression of miR-2188 in Tg(flk1-GFP)s843
zebrafish embryos, in which GFP is expressed in vascular
endothelial cells under the control of Flk (VEGFR2), down
regulates Nrp2a. This down regulation is accompanied by thinner
and underdeveloped ISVs, without through connections with the
dorsal longitudinal anastomotic vessel (DLAV). In some cases, lack
of one or more ISVs is observed. We also validate Nrp2a as an in
vivo target of miR-2188 demonstrating that miR-2188 modulates
the expression of a positive regulator of angiogenesis. This is the
first report of control of Nrp2a by a miRNA and indicates that the
development of proper ISVs during development is dependent on
the regulation of Nrp2a levels by a miR-2188 in zebrafish.
Results
miR-2188 Inhibits Nrp2a Expression
We have identified the zebrafish miR-2188 in a previous study
by deep DNA sequencing [15] and have used computational tools
to predict its putative targets. This analysis showed that miR-2188
has two putative binding sites in the 39UTR of Nrp2a (Table 1). In
order to experimentally validate this prediction, we have analyzed
miR-2188 and Nrp2a expression in zebrafish embryos by in situ
hybridization (ISH). Since miRNAs regulate gene expression, a
negative correlation between miRNA and target expression is
generally observed. In other words, the increase of miR-2188
expression in specific tissues should be accompanied by a decrease
in Nrp2a expression. MiR-2188 was detected at low levels at
24 hpf, but its expression increased at 48 hpf throughout the
embryo tail (Figure 1-A). On the other hand, Nrp2a was widely
expressed at 24 hpf but its expression became restricted to the
brain and romboencephalon after 48 hpf, confirming previous
studies (Figure 1-B) [19,24].
To test whether Nrp2a was a direct target of miR-2188, we have
induced miR-2188 deregulation by injecting a synthetic miR-2188
duplex to over express it or a morpholino (MO) to inhibit it, in one
cell zebrafish embryos (Figure 2-A). qPCR quantification showed
that over expression of miR-2188 decreased expression of Nrp2a,
whereas miR-2188 knockdown increased Nrp2a expression in
48 hpf embryos (Figure 2-B, C). ISH confirmed qPCR data as
there was a decrease in Nrp2a signal upon miR-2188 over
expression when compared with scrambled duplex injected
embryos at both 24 hpf (Figure 3– A-D) and 48 hpf (Figure 3–
I-L). Moreover, there was an increase in Nrp2a signal between the
somite boundaries after injection of the MOmiR-2188 at both 24 hpf
(Figure 3– E- H) and 48 hpf (Figure 3– M-P)). These results are
consistent with the target/anti-target theory which postulates that
miRNAs and their targets are expressed in a non-overlapping
manner, either spatially or temporally [31].
To further test if Nrp2a was a true target of miR-2188, we have
constructed a chimeric sensor assay based on a fusion between the
GFP coding region and the 39UTR of Nrp2a, which contained the
putative miR-2188 binding sites or mutated miR-2188 binding
sites (Figure 4-A). As expected, there was a strong down regulation
of GFP levels in the miR-2188 injected embryos (Figure 4-B, C).
On the other hand, binding site-1 mutation (M1), but not binding
site-2 mutation (M2), in the 39UTR of Nrp2a abolished the
inhibitory activity of miR-2188 on GFP expression (Figure 4-C),
demonstrating that Nrp2a is targeted in vivo by miR-2188 and that
its down regulation is mediated by a single binding site (binding
site 21) present in its 39UTR.
To further confirm that Nrp2a is a bona fide target of miR-2188,
we have performed rescue experiments where a MomiR-2188 was
injected in the presence of the miR-2188 duplex (Figure 5). Co-
injection of the MomiR-2188 and miR-2188 duplex resulted in the
recovery of the GFP expression, as observed both by fluorescence
microscopy (Figure 5-A) and western blotting (Figure 5-B),
confirming that Nrp2a is a miR-2188 target. Moreover, the
injection of a scrambled miRNA sequence had no effect on the
fluorescence levels and there was a slight increase of GFP
expression on miR-2188 morphants, as expected (Figure 5).
miR-2188 Affects Intersegmental Vessel Development
Since miR-2188 targets Nrp2a, which is a VEGF co-receptor
required for the correct development of major ISVs, we expected
disruption of this process in miR-2188 deregulated embryos. To
test this hypothesis we have used transgenic zebrafish embryos
expressing GFP in vascular endothelial cells under the control of
Flk [Tg(flk1-GFP)s843].
Nrp2 family members interact with FLK (VEGFR2) and with
other co-receptors to initiate the signaling pathways [21], thus it is
expectable that alteration in FLK levels is observed in transgenic
embryos after miR-2188 over expression. Previous studies have
Table 1. Putative binding sites of miR-2188 in Nrp2a 39UTR.
Nrp2a predicted
binding sites Match Mfe (kcal/mol)
Binding site-1 (BS-1) target 5‘ G G C U C C 39
GGA AU UG GG TGGACCUU
CCU UA AC CC ACCUGGAA
miRNA 3‘ G C U A 5’
226,9
Binding site-2 (BS-2) target 5‘ U AAC A A 39
GCA GGGUU GGACCU
UGU UCCAA CCUGGA
miRNA 3‘ CC ACAC A 59
222,1
doi:10.1371/journal.pone.0039417.t001
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malformations in the tail and irregular ISV patterning in zebrafish
embryos [19]. A similar phenotype was induced by miR-2188 over
expression (Figure 6, Figure S1). A delay or even absence of ISV
formation was observed at 24 hpf, likely due to a decrease in Nrp2a
expression caused by miR-2188 over expression (Figure 6– B).
This was confirmed at 48 hpf when ISVs were already formed and
differences in vessel development could be observed by confocal
microscopy (Figure 6 - C-E). Control embryos (uninjected and
scrambled injected embryos) had fully developed and thick ISVs
whereas miR-2188 injected embryos had thinner, underdeveloped
ISVs, with abrupt interruptions, lacking complete connections
with the dorsal vessel (Figure 6-B-D). On the other hand, injection
of the MOmiR-2188 induced ISV branching that often resulted in
DLAV defects (Figure 6-C, E). Therefore, over expression and
knocking down of miR-2188 affected angiogenesis differentially;
supporting the hypothesis that deregulation of miR-2188 interferes
with ISV development by regulating Nrp2a expression.
At 48 hpf 50% of the miR-2188 injected embryos displayed
circulation arrest and 70% had pericardial edema (Figure S1).
Absence of one or more ISVs was observed in 60% of the miR-
2188 injected embryos (Figure S1). These results indicated that
miR-2188 affected angiogenesis in zebrafish embryos and were
further substantiated by the injection of a MOmiR-2188 that blocked
processing and inhibited the activity of this miRNA. MOmiR-2188
injected embryos were mainly characterized by irregular develop-
ment of ISVs characterized by branching that often resulted in
DLAV defects when compared to control embryos (60%; Figure
S1; Figure 6– C, E). This phenotype was different from the
phenotype obtained after miR-2188 over expression, indicating
that over expression and knockdown of this miRNA affected
angiogenesis distinctly, supporting the hypothesis that deregulation
of miR-2188 interferes with angiogenesis.
This hypothesis was further confirmed by rescue experiments
where MOmiR-2188 was injected in embryos overexpressing miR-
2188. Co-injection of MOmiR-2188 with the miR-2188 duplex
rescued ISV patterning, indicating that de-regulated levels of miR-
2188 induce ISV defects (Figure S2).
Discussion
Experimental validation of miRNA targets is essential to
understand the functions of these small RNA molecules. Exper-
imental validation of predicted targets is often achieved by miRNA
gain or loss-of-function followed by monitoring mRNA and
protein levels of the predicted targets, or by monitoring the activity
Figure 2. miR-2188 duplex and morpholino injections. A) A miRNA duplex and a MOmiR-2188 were designed to over express and knockdown
miR-2188 in zebrafish embryos, respectively. Duplex microinjections were performed in one cell stage embryos with rhodamine to visualize the
injection process. Approximately 1000 pL of each duplex were injected. 2 mM of each duplex were chosen as the working concentration for the
injections, as this duplex concentration did not induce high mortality rates or unspecific side effects. B) qPCR quantification of miR-2188 showed that
miR-2188 duplex injection increased miR-2188 expression by 40 fold and MOmiR-2188 injection decreased miR-2188 expression by 12 fold. C) qPCR
quantification of Nrp2a levels in 48 hpf embryos after over expression and knockdown of miR-2188 showed that this target was down regulated 1.6
fold after miR-2188 over expression and was up regulated 2 fold after miR-2188 knockdown.
doi:10.1371/journal.pone.0039417.g002
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sites [32,33].
In this study, we have experimentally validated the miR-2188
target prediction obtained in a previous study [15]. The data show
that miR-2188 regulates Nrp2a, a VEGF co-receptor, which is
required for proper development of major ISVs in zebrafish [19].
Neuropilins increase the response to VEGF and are up regulated
in endothelial tumor cells [25]. The identification of a miRNA that
regulates vessel development and integrity by targeting a VEGF
receptor has therefore implications for vascular development.
We have demonstrated that the Nrp2a 39UTR is targeted by
miR-2188 in zebrafish embryos and that this miRNA interferes
with ISV development. Its over expression produced a similar
phenotype to that induced by a Nrp2a MO, supporting the
hypothesis that miR-2188 is implicated in angiogenesis by
regulating Nrp2a expression [19]. As expected, Nrp2a levels are
down regulated by miR-2188 over expression during early
developmental stages, which is incompatible with normal ISV
development in zebrafish. A decrease of Nrp2a expression is
observed in 24 and 48 hpf embryos injected with the miR-2188
duplex, supporting the hypothesis that miR-2188 regulates this
VEGF co-receptor. Conversely, knocking down miR-2188 with a
MOmiR-2188, results in Nrp2a up regulation at 24 and 48 hpf.
Interestingly, at 48 hpf the increase in Nrp2a expression is observed
between the somite boundaries and in the DA and PCV, regions
where Nrp2a is barely expressed in normal conditions. This
indicates that knocking down miR-2188 increases Nrp2a expres-
sion, which is likely responsible for the irregular ISV patterning
that often results in DLAV defects. This phenotype is distinct from
that obtained in embryos over expressing miR-2188, supporting
the hypothesis that deregulation of the latter interferes with ISV
patterning. Moreover, proper ISV patterning is rescued by
injection of MOmiR-2188 in embryos over expressing miR-2188.
Our data shows that miR-2188 interferes with proper ISV
development by directly targeting Nrp2a, indicating that
angiogenesis can be regulated at the level of VEGF receptors
by miRNAs. One cannot exclude that this miRNA may also
target other mRNAs involved in the VEGF pathway. Indeed,
miRNAs can be master regulators of key pathways by targeting
multiple mRNAs in a coordinated fashion [28,33–35]. For
example, miR-126 targets Spred1 and Pik3r2 genes, which are
involved in the VEGF pathway showing that angiogenesis and
vascular integrity can be disrupted by a single miRNA [28,29].
Also, the neuronal enriched miR-128 regulates Reelin and Dcx
Figure 3. ISH of Nrp2a after miR-2188 deregulation. A) After injection of miR-2188 duplex, Nrp2a detection decreased between the somite
boundaries at 24 hpf. On the other hand, in miR-2188 morphants, Nrp2a detection was more prounounced throughout the trunk and tail region,
between the somite boundaries, when compared with the control. B) At 48 hpf and after miR-2188 overexpression, Nrp2a was not detected in the
blood vessels or in the PCV when compared with the control embryos. On the other hand, miR-2188 morphants express Nrp2a in the trunck and tail,
especially between the somite boundaries, which is not detected in 48 hpf control embryos. All embryos are in lateral view, anterior to left. Arrows
indicate hybridization signal. Microscopic pictures were taken with a 6,3x magnification.
doi:10.1371/journal.pone.0039417.g003
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mechanisms [35], while miR-9 regulates the Fgf signaling by
inhibiting Fgf8, Fgfr1 and Canopy1 and exerts a proneurogenesis
effect by inhibiting expression of antineurogenic bHLH [33].
Therefore, one should not exclude the hypothesis that miR-
2188 has multiple targets, which were not detected due to the
high stringency of our initial prediction method. To clarify this
issue, we have repeated the target prediction analysis for miR-
2188 as before [15], by applying a lower stringent cutoff (with
perfect seed match between nucleotides 2 and 7 and allowing
up to 7 mismatches in the remaining sequence). This
methodology was able to retrieve 8 additional putative targets
for miR-2188, namely Nfe2l1, Has2, Myst3, Cpla2, Atg13, Dnajc3,
Dnaja3a and Pdik1l (Table 2). Most of the predicted target genes
are related with protein folding and heat shock response (Atg13,
Dnajc3 and Dnaja3a) and are necessary for the proper embryonic
development (Myst3). Interestingly, Cpla2 is involved in the
VEGF signaling pathway and regulates endothelial cell cycle
progression and angiogenesis [36]. In fact, it has been shown
that this gene promotes the angiogenic tubule formation as its
inhibition results in defects in the endothelial cell proliferation
machinery [36]. Moreover, this gene is highly expressed in
several carcinomas and is associated with tumor angiogenesis
[37]. Due to the involvement of this putative target in
angiogenesis, similarly to Nrp2a, future work should validate
Cpla2 as a miR-2188 target.
Nrp genes are widely conserved among vertebrate species. For
example, human Nrp2 and zebrafish Nrp2a orthologs have 57%
similarity [19], but miR-2188 has not been identified to date in
humans [38], suggesting that regulation of Nrp2a by miR-2188 may
Figure 4. GFP sensor assay. A) The GFP gene was fused with the 39UTR of Nrp2a that contained the putative binding sites of miR-2188. This
construct was transcribed in vitro into capped mRNA prior to injection. B) Single cell embryos were injected with the GFP reporter (50 ng/mL) in the
presence or absence of miR-2188 and scrambled duplexes. Fluorescence levels were observed at 24 hpf and representative embryos of each
condition were photographed. Decreased fluorescence was observed in miR-2188 duplex injected embryos. C) Embryo lysates were prepared from
24 hpf embryos injected with the wild type GFP reporter or the mutated reporters in the presence or absence of miR-2188 and scrambled duplexes.
Protein levels were determined by western blot analysis and b-tubulin was used as an internal control. D) Quantification of the reporter proteins (%)
in the conditions tested using 3 biological replicates. Asterisks indicate conditions where GFP expression was significantly down regulated by miR-
2188 relative to control conditions. miR-2188 injected embryos showed a statistically significant down regulation of GFP levels, indicating that Nrp2a
39UTR is a true miR-2188 target. Co-injection of the M1 reporter with the miR-2188 duplex produced normal GFP levels, indicating that the BS-1
mutation abolished miR-2188 binding. On the other hand, a significant decrease in GFP expression was observed after co-injection of the M2 reporter
with miR-2188, relative to the controls, indicating that BS-2 was not critical for miR-2188 binding. Data are mean +/2stdev, p,0,005 (t test, unpaired),
n.3. All lanes were normalized to the b-tubulin signal.
doi:10.1371/journal.pone.0039417.g004
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evolved and non-conserved miRNAs may regulate species specific
genes and may play a key role in evolutionary processes [39].
In conclusion, our data shows for the first time that miR-2188
targets Nrp2a, a positive regulator of angiogenesis, indicating that
the VEGF pathway can be regulated by miRNAs controlling
VEGF co-receptors.
Materials and Methods
Ethics Statement
All experiments were performed according to the European law
for animal experiments (2010/63/EU). No specific ethics approval
under EU guidelines was required for this project, as all zebrafish
used in this study were between 0 and 5 days old. This is within the
European law (Council Directive 86/609/EEC), which excludes
foetal and embryonic forms.
Wild type AB and Tg(flk1-GFP)s843 zebrafish were maintained
under the protocols approved by the Institutional Animal Ethics
Committee of the University of Lie `ge under application number
567. Zebrafish embryos were collected and kept at 28uC under
standard laboratory conditions, and staged as described [40].
miRNA Duplex Injections
A miR-2188 RNA duplex and a duplex containing a scrambled
sequence were obtained as siRNAs from SIGMA:
miR-2188: sense 59-AAGGUCCAACCUCACAUGUCCRNA-
39;
antisense 59-ACAUGUGAGGUUGGACCUURNA[dT][dT]-
39;
scrambled: sense 59-GUGUAACACGUCUAUACGCC-
CARNA-39;
antisense 59-GGCGUAUAGACGUGUUACACRNA[dT][dT]-
39; and were injected into one-cell fertilized embryos at 2 mM.
Figure 5. GFP rescue sensor assay. A) Single cell embryos were injected with the GFP reporter (50 ng/mL) in the presence or absence of MOmiR-
2188, miR-2188 and scrambled duplexes or a mixture of both MOmiR-2188 and miR-2188 duplex. Fluorescence levels were observed at 24 hpf and
representative embryos of each condition were photographed. Fluorescence was recovered in MOmiR-2188+ miR-2188 injected embryos, when
compared to miR-2188 duplex injected embryos. B) Embryo lysates were prepared from 24 hpf embryos injected with the GFP reporter in the
presence or absence of MOmiR-2188, miR-2188 and scrambled duplexes or a mixture of MOmiR-2188 and miR-2188. Protein levels were determined by
western blot analysis and b-tubulin was used as an internal control. C) Quantification of the reporter proteins (%). Asterisks indicate conditions where
GFP expression was significantly down regulated by miR-2188 relative to control conditions. miR-2188 injected embryos showed a statistically
significant down regulation of GFP levels, indicating that Nrp2a 39UTR is a true miR-2188 target. Co-injection of the MOmiR-2188 with the miR-2188
duplex resulted in the rescue of GFP fluorescence, further confirming that Nrp2a is a bona fide target of miR-2188. Data are mean +/2stdev, p,0,005
(t test, unpaired), n.3. All lanes were normalized to the b-tubulin signal.
doi:10.1371/journal.pone.0039417.g005
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duplex) diluted in TE buffer and 5% Rhodamine were injected in
one cell embryos. Embryos were staged and examined for
phenotypic alterations.
Morpholino Injections
The miR-2188 morpholino (MO) was obtained from Gene
Tools, diluted in Daniaeu Buffer and 5% Rhodamine and
1000 pL were injected in one cell embryos at 8 ng/mL. 1000 pL
of a control MO from Gene Tools was also injected at 8 ng/ml.
Phenotypes were assessed at 24 hpf and after blood circulation was
established.
Image Aquisition
24 hpf and 48 hpf control and injected (either with miRNA
duplexes or MOs) Tg(flk1-GFP)s843 embryos were dechorionated
and fixed in 4% PFA at 4uC for 4 h, washed 3 times in PBS-T and
stored at 4uC. For imaging, stored embryos were mounted in
Prolong and visualized using an OLYMPUS FV1000 confocal
microscope, equipped with FV-10ASW software, FITC filters and
a 488 nm laser. Images from control and injected embryos with
the duplexes or the MOs were acquired with 20x, 40x and 60x
objectives.
Quantitative Real-time PCR
Total RNA was extracted from embryos injected with the
miRNA duplexes, from embryos injected with miRNA MOs and
from control embryos at 48 hpf using Qiazol (Qiagen), following
the manufacturer’s protocol. Samples were treated with DNase to
remove any contaminating genomic DNA. RNA quantity and
quality were assessed using the Nanodrop and Agilent 2100
bioanalyzer systems, respectively. Samples with a RNA integrity
number (RIN) above 7 were used in this study.
Quantification of miR-2188 expression was carried out using
NCode
TM miRNA first-strand cDNA module and PlatinumH
SYBRH Green qPCR Super Mix-UDG from Invitrogen. Briefly,
miRNAs were polyadenylated using poly-A polymerase and ATP.
cDNA was then prepared from 500 ng of total RNA with the
SuperScriptH III RT and a Universal RT primer, following the
manufacturer’s protocol. Quantitative real-time PCR (qPCR) was
performed with the synthesized cDNA using SYBRH Green
detection reagent, the Universal qPCR primer provided in the kit,
and a forward primer designed to target miR-2188 (59-AAGGTC-
CAACCTCACATGTCC-39). U6 small RNA was used as an
endogenous control for normalizing miRNA levels.
Quantification of Nrp2a was carried out using Power SYBRH
Green PCR Master Mix from Applied Biosystems. cDNA was
Figure 6. Analysis of blood vessel formation in Tg(flk1-GFP)s843 embryos. A) Representation of the zebrafish circulatory system showing
the major structures (DLAV - Dorsal Longitudinal Anastomotic Vessel; ISV – Intersegmental Vessel; DA – Dorsal Aorta; PCV – Posterior Cardinal Vein).
B) Visualization of 24 hpf embryo blood vessels using fluorescence microscopy. After miR-2188 duplex microinjection under developed and absent
ISVs were observed, non injected and scrambled duplex injected embryos did not show such defects. C) Visualization of 48 hpf embryo blood vessels
using confocal microscopy (20x). ISVs of miR-2188 injected embryos were thinner than those of non injected and scrambled duplex injected embryos
and displayed ISV’s patterning defects (arrows). MOmiR-2188 injected embryos revealed DLAV defects and branching of ISVs (arrows). Images shown in
D) and E) are 60x amplification images of miR-2188 duplex and miR-2188-MO injected embryos, respectively.
doi:10.1371/journal.pone.0039417.g006
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(Invitrogen) following the manufacturer’s instructions. qPCR was
performed with the synthesized cDNA using Power SYBRH Green
detection reagent and forward (59-TGGAGCTACTCTGTTC-
CAGC-39) and reverse (59- TGTCCAAAGAGAGACTGGGA-
39) Nrp2a primers. Tubulin a-1 was used as an internal control for
normalizing mRNA levels as its expression level is relatively
constant across tissues and it is not significantly altered by
experimental conditions [41].
Efficiency of primers was determined after the generation of a
standard curve. All reverse transcriptions and no-template controls
were carried out simultaneously following the RT step. qPCR was
carried out using the ABI Prism 7500 Sequence Detector System
(Applied Biosystems). Reactions were incubated in 96-well optical
plates and cycling began with template denaturation at 95uC for
2 min, followed by 50 cycles at 95uC for 15 seconds and 60uC for
35 seconds for miR-2188 detection. For Nrp2a detection, cycling
began with template denaturation at 95uC for 10 min, followed by
40 cycles at 95uC for 15 seconds and 60uC for 1 min. The
threshold cycle data (CT) and baselines were determined using
auto settings. All assays including no template controls were
carried out in triplicate. The REST software [42] was used to
quantify Nrp2a and miRNA levels. In our dataset the control
Table 2. Putative targets of dre-miR-2188.
Gene ID (ZFIN) Gene name
GO
Molecular Function
GO
Biological process
GO
Cellular component
Nfe2l1 nuclear factor, erythroid derived
2,-like 1a
Binding: DNA Regulation of transcription Nucleus
Has2 hyaluronan synthase 2 Hyaluronan synthase
activity; Transferase
activity, transferring
hexosyl groups
atrioventricular valve
development; cell migration
in hindbrain; cell migration
involved in gastrulation;
dorsal convergence;
embryonic heart tube
development; heart looping;
hyaluran biosynthetic
process; mesodermal cell
migration; metabolic process;
somitogenesis
Membrane
Myst3 K(lysine) acetyltransferase 6A DNA binding; transferase
activity; zinc ion binding
anterior/posterior pattern
specification; cartilage
development; embryonic
body morphogenesis;
embryonic pattern
specification; embryonic
skeletal system development;
embryonic viscerocranium
morphogenesis; histone
acetylation; neural crest cell
fate specification;
nucleosome assembly;
regulation of transcription,
DNA-dependent
Nucleus; Nuclear chromatin;
Nucleosome;
Cpla2 cytosolic phospholipase a2 hydrolase activity;
lysophospholipase activity;
metal ion binding;
phospholipase activity
lipid catabolic process;
metabolic process; ovarian
follicle development;
phospholipid catabolic
process
cytoplasm; cytoplasmic
membrane-bounded vesicle;
cytoplasmic vesicle
Atg13 Autophagy related protein 13 molecular autophagy cytoplasm; cytosol; pre-
autophagosomal structure
Dnajc3 DnaJ (Hsp40) homolog, subfamily C,
member 3
binding; heat shock
protein binding; unfolded
protein binding;
protein folding cellular component
Dnaja3a DnaJ (Hsp40) homolog, subfamily A,
member 3A
ATP binding; heat shock
protein binding; metal
ion binding; unfolded
protein binding
protein folding; response
to heat
unknown
Pdik1l PDLIM1 interacting kinase 1 like ATP binding; kinase
activity; nucleotide
binding; protein kinase
activity; protein
serine/threonine kinase
activity; transferase
activity; transferase
activity, transferring
phosphorus-containing
groups
phosphorilation; protein
phosphorilation
nucleus
doi:10.1371/journal.pone.0039417.t002
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MO injections).
In Situ Hybridization
In situ hybridization was carried out as described [43] with a
Nrp2a probe kindly provided by the Laboratory of Molecular
Biology and Genetic Engineering, Lie `ge University. After staining,
embryos were washed 4 times with TBS-T. Embryos were
mounted in 100% glycerol and photographed using a color digital
camera.
miR-2188 ISH was carried out with a LNA probe from Exiqon
(/5DigN/GGACATGTGAGGTTGGACCTT/3Dig_N/, Tm
79uC). Briefly, 24 hpf and 48 hpf embryos were collected and
prepared for ISH as described above. Incubations with hybrid-
ization mix and miR-2188 probe were performed at 61uCt o
minimize unspecific hybridization. 10 nM of miR-2188 probe
were used for the ISH.
Sensor assay
The pCS2+ plasmid containing eGFP (gift from Dr. Hyangshuk
Rhim, Research Institute of Molecular genetics, Catholic Univer-
sity of Korea), was used in this study. The 39UTR of Nrp2a
containing putative miR-2188 binding sites was fused to the 39 end
of eGFP using StuI and XhoI. The 39 UTR of Nrp2a was
amplified using the following primers:
Forward: 59-GCGCAGGCCTTCCTAAAATGACCT-
CAAAGT-39.
Reverse: 59-GCGCCTCGAGGTATATCGAGTGTTTAA-
GAC-39.
Nrp2a 39UTR sequences carrying point mutations in the
predicted miR-2188 binding sites were engineered by site directed
mutagenesis. A M1 construct containing mutations in the binding
site-1 (BS-1) was generated using the following primers: Forward:
59-GGGAGATCTGTGGCCGGGACCCCGAGCCAT-
GAACTTCTGTCC-39 Reverse: 59-GGACAGAAGTT-
CATGGCTCGGGGTCCCGGCCACAGATGTCCC-39.
A M2 construct containing the mutation in the binding site-2
(BS-2) was generated with the following primers:
Forward: 59-TTTGCAAACGGGTTAGTGCTGAACACT-
GAGCCTTGAGG-39.
Reverse: 5’-CCTCAAGGCTCAGTGTTCAGCAC-
TAACCCGTTTGCAAA-3’.
Highlighted nucleotides show the mutations inserted in the
39UTR. Point mutations were PCR amplified and fused to the 39
end of eGFP, as described above. For all constructs, capped
mRNA was prepared to avoid degradation after microinjection,
using the mMESSAGE mMACHINE SP6 Kit (Ambion), accord-
ing to manufacturer’s protocol. The mRNA (final concentration
50 ng/mL) was injected with either miR-2188 duplex or the
control miRNA duplex containing a scrambled miRNA sequence
(final concentration 2 mM). Approximately 1000 pL of the mixture
of mRNA and duplex were injected and embryos were pooled and
prepared for western blot analysis at 24 hpf.
Western Blot
24 hpf embryos were pooled (20–30 embryos each) and embryo
extracts were prepared after dechorionation and deyolking.
2xSDS sample buffer was added, followed by denaturation at
95uC for 5 min followed by vortexing. The protein solution was
centrifuged for 2 min using a table-top centrifuge and samples
were directly loaded onto 15% PAA protein gels and electropho-
resed in SDS running buffer. Proteins were transferred overnight
at 4uC to PVDF Hybond-P membranes (GE Healthcare), which
were blocked for 1 h with 4% nonfat dry milk in TBS-T.
Immunodetection was carried out using monoclonal anti-Green
Fluorescent Protein mouse antibody (1:1000) from Clonetech and
anti b-tubulin mouse antibody (1:500) from Invitrogen, as primary
antibodies. IRDyeH800 CW Goat anti-mouse IgG from LI-CORH
was used as secondary antibody (1:10000). Detection was carried
out using OdisseyH Imaging System.
Supporting Information
Figure S1 Developmental defects observed after miR-
2188 duplex and MomiR-2188 injections. At 48 hpf develop-
mental defects were quantified. Scrambled and MOCtrl injected
embryos developed similarly to non-injected embryos, while
embryos injected with the miR-2188 duplex revealed high
incidence of pericardial edema (70%) and circulation arrest
(50%). More than 50% of the embryos lacked one or more ISVs.
MOmiR-2188 injected embryos showed ISV branching (50%) that
often resulted in dorsal longitudinal anastomotic vessel (DLAV)
defects (50%). Twenty four embryos were analyzed per condition
(n.3).
(TIFF)
Figure S2 ISV patterning is rescued after injection of
MomiR-2188 in embryos overexpressing miR-2188. Visual-
ization of 48 hpf embryo blood vessels using confocal microscopy
(20x). ISVs of miR-2188 injected embryos were thinner and
displayed ISV patterning defects, when compared to non-injected
embryos. Injection of MO miR-2188 in embryos over expression
miR-2188 rescued the ISV patterning.
(TIFF)
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